A Pilot Study of Inflammatory Markers in Alzheimer's Disease
Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the cerebrospinal fluid (CSF) of patients with
Alzheimer's disease for biomarkers of inflammation and their response to the antibiotics
doxycycline and rifampin. The results of this preliminary analysis will be used in defining
the direction of further research.